Zhang et al. (71) has documented the efficacy of Kaempferol in conjunction with erlotinib (ERL), an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), for preventing the growth of PC. Here, EGFR is linked to pachyonychia congenita.